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Abstract
Background: Gastroschisis patients are commonly small for gestational age (SGA, birth weight [BW] < 10
th centile).
However, the extent, symmetry and causes of that growth restriction remain controversial.
Methods: We compared BW, crown-heel length (LT), occipitofrontal circumference (OFC) and ponderal index (PI) in
179 gastroschisis cases and 895 matched controls by univariate and multiple regression. Fetal ultrasounds (N = 80)
were reviewed to determine onset of growth restriction. Placental histology was examined in 31 gastroschisis
patients whose placental tissue was available and in 29 controls.
Results: Gastroschisis cases weighed less than controls (BW = 2400 ± 502 g vs. 2750 ± 532 g, p < 0.001) and their
BW frequency curve was shifted to the left, indicating lower BW as a group compared to controls (p < 0.001 by
Kolmogorov-Smirnov test). BW differences varied from -148 g at 33 weeks to -616 g at 38 weeks gestation.
Intrauterine growth restriction was symmetric with gastroschisis patients having a shorter LT (45.7 ± 3.3 vs. 48.4 ±
2.7 cm, p < 0.001), smaller OFC (31.9 ± 1.9 vs. 32.9 ± 1.6 cm, p < 0.001), but larger ponderal index (2.51 ± 0.37 vs.
2.40 ± 0.16, p < 0.001) compared to controls. Gastroschisis patients had a similar reduction in BW (-312 g, 95%
confidence interval [CI] = -367, -258) compared to those with chromosomal abnormalities (-239 g, CI = -292, -187).
Growth deficits appeared early in the second trimester and worsened as gestation increased. Placental chorangiosis
was more common in gastroschisis patients than controls, even after removing all SGA patients (77% vs. 42%, p =
0.02).
Conclusions: Marked, relatively symmetric intrauterine growth restriction is an intrinsic part of gastroschisis. It
begins early in the second trimester, and is associated with placental chorangiosis.
Background
Gastroschisis is a unique congenital anomaly appearing
as a defect in the abdominal wall usually to the right of
the umbilicus. It commands increasing interest because
of its rising prevalence [1-4] and clinical impact [5,6].
Most gastroschisis cases present with an isolated anom-
aly, which develops around the 6
th gestational week [7]
and is not usually associated with chromosomal
abnormalities [8,9]. However, almost all studies report
gastroschisis patients have an increased risk of being
small for gestational age (SGA, birth weight [BW] < 10
th
centile) [6,10-13]. Previous fetal studies reported not
only a high prevalence of SGA (up to 61%), but also a
leftward shift in the BW distribution compared to
intrauterine fetal growth curves [11,13]. Determining the
appropriate comparison standard for gastroschisis cases
may not be straightforward, since these patients’
mothers have a unique demographic profile that may
differ from that of the population from which the stan-
dards were developed [14-19]. Mothers of gastroschisis
patients are more likely to be young, primigravida,
undernourished, smokers, and tend to have a low BMI,
[2,15-19] all factors that are also associated with
decreased intrauterine growth [20] and which might
confound any association of gastroschisis with intrauter-
ine growth. The extent, symmetry and causes of growth
restriction remain controversial. The purpose of this
study was to characterize and quantitate the fetal growth
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placental dysfunction as a cause of this growth deficit.
Methods
Study design
This retrospective, case-control study was a secondary
analysis of data collected on all newborns admitted to
the NICUs of Children’s Hospitals and Clinics of Min-
nesota. We conducted four analyses in this study. Analy-
sis #1) We compared BW, crown-heel length (LT),
occipitofrontal circumference (OFC), and ponderal
index (PI) at birth in gastroschisis cases to that in
matched controls without major congenital anomalies
and to neonatal and fetal growth standards [21-24].
Analysis #2) We examined the same measures of size at
birth comparing gastroschisis patients to other groups
of anomalies: a) isolated gastrointestinal (GI) anomalies
other than gastroschisis, b) isolated renal anomalies, c)
isolated cardiac anomalies, d) chromosomal anomalies,
e) all other anomalies, and f) those with no recorded,
major anomaly (Figure 1). Analysis #3) We examined
estimated fetal weight determined by prenatal
ultrasound in gastroschisis patients. Analysis #4) Finally,
we examined placental findings in gastroschisis patients
and controls.
Subjects
Our study population was live-born patients with gas-
troschisis. The study sample included all gastroschisis
cases admitted to Children’s Hospitals and Clinics of
Minnesota either at the Minneapolis campus from 1
January 1990 to 31 December 2007 or at the St. Paul
campus from 1 January 2004 to 31 December 2007 (Fig-
ure 1). We identified 179 cases of gastroschisis. There
were no delivery room deaths among gastroschisis
patients. Information on terminations, stillbirths, and
fetal deaths was not available. The Institutional Review
Boards of Children’s Hospitals and Clinics of Minnesota
(No. 0811-104) and Abbott Northwestern Hospital (No.
2558-1E) approved this study.
For the first analysis, we matched five controls to each
case on a case-to-case basis by gestational age, gender,
and multiple gestation status, using computerized ran-
dom sampling of potential controls without replacement
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Figure 1 Flow diagram showing the total study population, exclusions, and final sample sizes. Percentages are calculated using the total
number of available patients before exclusions.
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Page 2 of 11(Table 1). Since half of all gastroschisis patients are born
at ≤36 weeks gestation and virtually all infants with
gestational age ≤36 weeks gestation are admitted to a
NICU, controls came from the same NICU population
as cases (N = 28,368, Figure 1). We excluded potential
controls with missing data (N = 4315, 15.2%) or major
anomalies (N = 5091, 17.9%) (Figure 1). For the pur-
poses of this study, the following recorded diagnoses
and procedures represented or potentially represented
major anomalies: renal malformations, congenital heart
disease (excluding patent ductus arteriosus), central ner-
vous system malformations, chromosome abnormalities,
major skeletal anomalies, recognizable dysmorphic syn-
dromes and thoracic, abdominal, head/neck, or heart
surgery. No congenital infections were diagnosed in
cases or controls. To minimize the risk of bias in con-
trols’ growth measures, [25,26] we included only
patients with admission diagnoses unlikely to be
Table 1 Characteristics of study cases and controls
Feature Gastroschisis (n = 179) number (%) Controls (n = 895) number (%) p-value
a
Gestational age (weeks) (mean ± sd) 36 ± 2 36 ± 2 1.000
Maternal age (years) (mean ± sd) 22 ± 4 30 ± 3 <0.001
Age ≤ 20 years (%) 69 (38.6) 44 (5.0)
Age 20-24 years (%) 70 (39.1) 154 (17.2)
Age 25-29 years (%) 31 (17.3) 248 (27.7)
Age ≥ 30 years (%) 9 (5.0) 449 (50.2)
Maternal race <0.001
Caucasian (%) 140 (78.2) 741 (82.8)
African American (%) 7 (3.9) 90 (10.1)
Asian (%) 19 (10.6) 38 (4.3)
Hispanic (%) 8 (4.5) 20 (2.2)
Native American (%) 5 (2.8) 6 (0.7)
Female 84 (47.0) 420 (47.0) 1.000
Inborn (%) 155 (86.6) 697 (77.9) 0.008
Birth weight <10
th centile
b (%) 44 (24.6) 69 (7.7) <0.001
Gestational hypertension/pre-eclampsia (%) 0 148 (16.5) N/A
e
Single (%) 113 (63.1) 224 (25.0) <0.001
Minor anomalies (%) 24 (13.4) 39 (4.4) <0.001
Multiple gestation 4 (2.2) 20 (2.2) 1.000
Primigravida 110 (61.5) 285 (31.8) <0.001
Gestational diabetes
f 1 (0.6) 63 (7.3) 0.010
Pre-existing (before pregnancy) diabetes
f 0 27 (3.3) N/A
e
Maternal smoking 52 (29.1) 138 (15.4) <0.001
Maternal illicit drug use 7 (3.9) 32 (3.6) 0.829
Maternal alcohol use 7 (3.9) 16 (1.8) 0.082
Center (Minneapolis) 155 (86.6) 767 (85.7) 0.754
Era (1999-2007) 129 (72.1) 581 (64.9) 0.065
Birth weight (g) 2400 ± 502 2750 ± 532 <0.001
Birth weight z-score -0.65 ± 0.86 0.11 ± 0.49 <0.001
Crown-heel length (cm) 45.7 ± 3.3 48.4 ± 2.7 <0.001
Crown-heel length z-score
c,d -0.50 ± 1.19 0.68 ± 0.55 <0.001
Occipitofrontal circumference (OFC) 31.9 ± 1.9 32.9 ± 1.6 <0.001
OFC z-score
d (cm) -0.36 ± 0.87 0.24 ± 0.45 <0.001
Ponderal index 2.51 ± 0.37 2.40 ± 0.16 <0.001
Ponderal index z-score -0.06 ± 0.85 -0.30 ± 0.34 <0.001
a Determined for continuous variables using paired t-test comparing the gastroschisis cases as individuals and the mean of the five matched controls’ values as
the paired control. Determined for the selected dichotomous and categorical variables using conditional logistic regression with adjustment for matching.
b Small for gestational age status determined as BW < 10
th centile for gestational age using the standards of Fenton, et al.[21]
c Z-scores calculated by method of Cole, et al.[22]
d Length and OFC were missing in two gastroschisis cases, N = 177 for paired t-tests.
e Unable to estimate p-value with no cases in one or more cells.
f Presence or absence of pre-existing and gestational diabetes missing for 12 cases and 11 controls.
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ity, respiratory distress, R/O sepsis, unstable tempera-
ture, and “observation status.”
For the 2
nd analysis, we examined additional patient
groups with isolated renal (N = 37), GI anomalies other
than gastroschisis (N = 130), cardiac (N = 405), chromo-
somal (N = 479) and any other congenital anomaly (N =
4040, Figure 1). Isolated renal anomalies included 26
cases with hydronephrosis and 11 cases of multicystic/
polycystic kidneys. Isolated GI anomalies included
imperforate anus- 52 cases, Hirschsprung’s Disease- 47,
and intestinal atresia- 31. The three most commonly
recorded cardiac diagnoses were d-transposition of the
great arteries- 114, hypoplastic left heart syndrome- 74,
and aortic coarctation- 63 cases. The three most com-
mon chromosomal anomalies were trisomy 21- 225, tris-
omy 18- 31, and trisomy 13- 16 cases. All remaining
patients with major anomalies were included in the final
group of “any other major anomaly”. These four groups
of major anomalies and the gastroschisis cases were
compared to the 15,788 patients without major anoma-
lies (Figure 1).
For the 3
rd analysis using prenatal ultrasound data,
there were 80 women with at least one available ultra-
sound evaluation. For the 4
th analysis, there were 31
gastroschisis and 29 control patients with available pla-
cental tissue.
Neonatal clinical data
Data were collected concurrent with hospitalization as
part of an ongoing NICU outcomes monitoring project.
BW, LT, and OFC were obtained by NICU nurses and
neonatal nurse practitioners. Prenatal ultrasounds were
interpreted by board-certified perinatologists. Fetal
weight estimates were based on the standards of Had-
lock, et al [14]. A board-certified pathologist (MAA) or
pediatric pathologist (SCS) reviewed placental histologi-
cal findings. Placental weight was obtained after drain-
ing, trimming, and patting the placenta dry. The
placental weight z-score was calculated using published
standards [27,28].
Clinical definitions
Gestational age came from obstetrical estimates based
on last menstrual period and corrected by early second
trimester ultrasound, if available. If physical exam indi-
cated a gestational age > 2 weeks different from the
obstetrical estimate, the estimate from the physical
exam was used. Small for gestational age (SGA) was
defined as BW < 10
th centile [21]. Ponderal index (PI),
average neonatal weight gain and fetal growth were
assessed using published standards [24,28,29]. Ponderal
index was defined as weight in kg divided by length in
meters cubed [23]. Gestational hypertension and pre-
eclampsia were determined by the treating obstetrician’s
assessment and collapsed into a single group, gestational
hypertension. Maternal smoking, a dichotomous vari-
able, was determined by the mother’sr e p o r ta sp r e s e n t
if the mother smoked after she knew she was pregnant.
Placental analysis
We examined the original slides of available placentas to
determine the presence of abnormalities. All slides were
examined by a board-certified pediatric pathologist
(SCS). The diagnosis of chorangiosis, capillary prolifera-
tion in placental terminal villi, was made using the defi-
nition of Altschuler and Baergen [30,31] with slight
modication as follows: 1) Focal chorangiosis was defined
as > 10 capillaries in > 10 terminal villi in 10 fields at
10× magnification in each of 1-2 of 3 slides. Diffuse
chorangiosis was defined as > 10 capillaries in > 10
terminal villi in 10 fields at 10X magnification in each
of 3 slides. Chorangiosis usually represents chronic
hypoxic environment for the fetus and manifests an
attempt to enlarge the placental diffusional surface
[30,31].
Statistical analysis
For the 1
st analysis, we compared cases with matched
controls using univariate conditional logistic regression
for dichotomous and categorical variables. Continuous
variables were compared by the paired t-test after aver-
aging values for the five controls, thus consolidating the
five controls’ values into a single value. BW distributions
of cases and controls were analyzed using the Kolmoro-
gov-Smirnov test. We adjusted for possible covariates
using multiple linear regression. We included in the
regresion equation all available variables that were asso-
ciated with BW by univariate analysis with a p-value <
0.10 or that might reasonably influence BW [20]. Sub-
stantial collinearity was not present (variance inflation
factors, 1.02 - 1.71). Gestational age, gender, and multi-
ple gestation accounted for 50% of the variation in BW.
These variables were not included in the regression ana-
lysis because they were perfectly matched among cases
and controls. The regression equation without these
variables explained 10% of the variation in BW and LT,
9% of the variation in OFC and 7% in the variation of
PI. Our study had >99% power to detect a ≥10% differ-
ence in the mean BW of gastroschisis patients and con-
trols at the p = 0.05 level. For analysis #2, we also used
multiple regression to compare the different groups
with anomalies to the group without anomalies. We
included the same covariates as above and added gen-
der, gestational age and multiple gestation, since these
data were not matched. Variance inflation factors were
1.01 - 1.13. Regression results accounted for 82%, 81%,
78% and 10% of the variation in BW, LT, OFC, and PI
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tive statistics and sign ranks tests to compare prenatal
ultrasound estimates of fetal weight and birth weight.
For analysis #4, we used the Fisher exact test to com-
pare placental findings in cases and controls. We used
only 2-sided p-values and made no adjustment for mul-
tiple comparisons. All analyses were performed with
Stata, version 11.1 (College Park, TX).
Results
Patient population and demographics
We identified 179 gastroschisis cases to whom we
matched 895 controls (5:1 ratio, Figure 1) with the fol-
lowing admission diagnoses: respiratory distress (N =
390), prematurity (N = 353), rule out sepsis (N = 67),
need for observation (N = 72), and unstable temperature
(N = 13). Mothers of gastroschisis cases were signifi-
cantly younger, more commonly single, Asian, primigra-
vid, and less likely to have gestational hypertension
compared to mothers of controls (Table 1). Gastroschi-
sis cases were more likely to be inborn, SGA and have
minor anomalies (in addition to gastroschisis) compared
to controls (Table 1). Examples of these relatively minor
anomalies were supernumerary digit, talipes equinovarus
deformity, and cyst in filum terminale. SGA was more
common among gastroschisis patients across all mater-
nal age groups (Figure 2).
#1 Analysis: Case-control comparison
Mean BW of gastroschisis cases was 350 grams less than
controls (Mean ± standard deviation [sd]), 2400 ± 502
vs. 2750 ± 532 grams, p < 0.001). The BW frequency
curve for gastroschisis cases was shifted to the left com-
pared to controls, suggesting that gastroschisis cases
overall had significantly lower BW than controls (Figure
3, Kolmogorov-Smirnov test, p < 0.001). Generalized
Lorenz graphs of the cumulative mean birth weight also
demonstrated this difference (Figure 4). Similarly, mean
length was 2.7 cm shorter (LT 45.7 ± 3.3 vs. 48.4 ± 2.7
cm, p < 0.001) and mean OFC was 1.0 cm smaller (31.9
± 1.9 vs. 32.9 ± 1.6 cm, p < 0.001) than controls (Table
1). The PI was slightly higher than that of controls (2.51
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Page 5 of 11vs. 2.40, p < 0.001). These findings were consistent with
relatively symmetric growth restriction.
Since the gastroschisis babies who were severely
growth restricted, BW < 10
th centile, might skew the
analysis, we repeated the comparisons after eliminating
the 44 SGA cases and their associated controls. Gastro-
schisis cases were still lighter by 199 g (2530 ± 489 vs.
2729 ± 563 g, p < 0.001), shorter by 1.9 cm (46.4 ± 3.1
vs. 48.3 ± 2.8 cm, p < 0.001), and had a smaller OFC by
0.6 cm (32.2 ± 1.9 vs. 32.8 ± 1.7 cm., p < 0.001) com-
pared to controls. Similarly, PI was again very slightly
higher in cases than controls (2.5 ± 0.4 vs. 2.4 ± 0.2, p <
0.001). Growth restriction occurred across the BW dis-
tribution of gastroschisis patients whether or not they
met the technical definition of SGA (Figure 3).
We then adjusted for other demographic features that
might confound the association of poor fetal growth and
gastroschisis. Black race, Asian race, maternal hyperten-
sion, illicit drug use and nulliparity were all negatively
associated with BW (Table 2). Maternal diabetes was
positively associated with BW. After adjustment for
potential confounders, there remained a 317 g reduction
in BW (95%CI = -415, -218, p < 0.001), a 2.5 cm reduc-
tion in LT (95% CI = -3.1, -1.9, p < 0.001), 0.8 cm
reduction in OFC (95% CI = -1.1, -0.5), and a similar
increase in PI of 0.1 (95% CI = 0.03, 0.17, p = 0.006)
with gastroschisis compared to controls (Table 2). There
was an interaction between gastroschisis and gestational
age. From 33 to 38 weeks gestation, the BW difference
between cases and controls increased from -148 g to
-616 g (7% to 18% of controls’ BW, Figure 5). Therefore,
gastroschisis patients became progressively lighter com-
pared to controls of the same gestational age.
Slow neonatal growth exacerbated slow intrauterine
growth. Mean weight gain for gastroschisis cases was 6.5
g/kg/day. Gastroschisis cases dropped from a mean BW
z-score of -0.65 ± 0.86 (31st centile) at birth to -0.94 ±
0.79 (23rd centile) at discharge. Although cross-sectional
birth weight standards are not designed to measure
longitudinal growth, our findings suggested that postna-
tal growth deficits compounded those occurring before
birth in gastroschisis cases.
#2 Analysis: Comparison of gastroschisis and other
patients with anomalies
We then examined intrauterine growth restriction in
gastroschisis cases compared to other patients with
major anomalies (Table 3). Gastroschisis, chromosomal
anomalies and isolated congenital heart disease were all
associated with significantly lower BW when compared
Table 2 Unadjusted and adjusted analysis of birth weight among gastroschisis patients and Controls
Unadjusted Adjusted
Coefficient
a 95% CI
b p-value Coefficient
c 95% CI
b p-value
Gastroschisis -350 -415, -286 <0.001 -317 -415, -218 <0.001
Gestational age (weeks) 228 213, 244 <0.001 ND
c ND ND
Male gender 107 -39, 253 0.151 ND
c ND ND
Multiple gestation -241 -391, -92 0.002 ND
c ND ND
Maternal race/ethnicity
White Referent Referent
African American -250 -363, -136 <0.001 -236 -368, -104 0.001
Native American 1 -429, 431 0.996 277 -181, 735 0.235
Asian -219 -344, -95 0.001 -178 -301, -55 0.005
Hispanic -182 -480, 115 0.229 -178 -510, 155 0.292
Gestational diabetes 134 -53, 323 0.160 77 -106, 260 0.407
Pre-existing diabetes 628 348, 908 <0.001 689 406, 973 <0.001
Maternal smoking -220 -313, -128 <0.001 -142 -249, -34 0.010
Maternal hypertension -251 -372, -129 <0.001 -354 -473, -234 <0.001
Maternal illicit drug use -378 -545, -211 <0.001 -255 -453, -58 0.012
Maternal alcohol use -390 -603, -176 0.005 -143 -358, 71 0.189
Single mother -234 -316, -152 <0.001 -59 -161, 42 0.250
Maternal age (years) 13 7, 18 <0.001 -2 -9, 6 0.654
Nullipara -164 -246, -82 <0.001 -98 -192, -6 0.037
Outborn (yes = 1, no = 0) 239 141, 337 <0.001 136 42, 230 0.005
Era (1999-2007) 1 -72, 74 0.980 27 -44, 98 0.452
a Obtained by univariate regression
b CI= 95% confidence interval
c Adjusted coefficient obtained by multiple regression. Since cases and controls were perfectly matched for gestational age, gender, and multiple gestation, these
variables were not included in the multiple regression analyses. All other potential covariates were included (see methods).
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covariates by multiple regression analysis, gastroschisis
was associated with a 312 g (CI 368, 259; p < 0.001)
reduction in BW compared to infants with no major
anomalies. The BW reduction associated with gastro-
schisis was somewhat larger than that seen with chro-
mosomal anomalies (234-g reduction, CI -285, -182; p <
0.001 grams). LT and OFC showed similar differences
before (Table 3) and after adjustment for covariates
(data not shown). Gastroschisis was unique among the
groups of anomalies that we examined in causing severe
growth restriction, similar in degree to that seen with
chromosomal abnormalities.
#3 Analysis: Onset of decreased intrauterine growth
We reviewed the prenatal ultrasounds of 80 women
pregnant with a baby with gastroschisis. Their first
ultrasound was obtained at a median of 26 weeks (range
21 - 38) gestation. At the first ultrasound, almost all
gastroschisis patients had a low estimated fetal weight
(median estimated fetal weight centile = 27, range 3 -
70). Among those with more than one fetal ultrasound,
32/54 (59%) had either a drop or no change in esti-
mated fetal weight centile between the first and last fetal
weight estimate. The mean (±sd) time between the first
and last fetal ultrasound was 9 ± 3 weeks. Fetal growth
restriction appeared by at least the second trimester and
generally worsened as gestation advanced.
We then compared estimated fetal weight percentile
and birth weight percentile in the 61 women who had
an ultrasound within 3 weeks of delivery (Table 4). Esti-
mated fetal weight was lower than actual birth weight,
but this was probably attributable to the interval
between the last ultrasound measurement and delivery.
Estimated fetal weight percentile and measured birth
weight percentile did not differ (Table 4).
#4 Analysis: Placental abnormalities associated with
gastrochisis cases
We examined the placental weight, placental weight z-
scores and histology in the 31 available placentas from
gastroschisis cases and from 29 controls. There was no
significant relationship between placental wt z-score and
BW z-score (R = 0.204, p = 0.063). However, placentas
of gastroschisis cases had a significantly higher preva-
lence of chorangiosis (81% vs. 41%, p = 0.003) and vil-
lous edema (33% vs. 0%, p = 0.005), but not
chorioamnionitis (42% vs. 48%, p = 0.796, Table 5).
Even after removing SGA patients (chorangiosis is asso-
ciated with SGA), placentas from gastroschisis patients
still had chorangiosis more frequently than controls
(77% vs. 42%, p = 0.02). Representative photomicro-
graphs of chorangiosis in the placenta associated with a
gastroschisis case and no chorangiosis in a control
appear in Figures 6 and 7, respectively. Among patients
with chorangiosis, only one (a gastroschisis case) infant’s
mother had diabetes, a condition also known to be asso-
ciated with chorangiosis. No other significant findings
were seen, such as infarcts or fibrinoid deposition.
Discussion
Our study further characterizes the association of poor
fetal weight gain and gastroschisis that has been
reported by others [5,6,10-13,32-34]. Intrauterine growth
restriction of some degree often accompanies gastroschi-
sis, even when the BW percentile is > 10
th percentile
[11]. In many cases, the degree of growth restriction is
marked. The adjusted mean growth deficit with gastro-
schisis was 317 g. This growth deficit could not be
explained by maternal factors, which might be common
to mothers delivering a baby with either gastroschisis or
with growth restriction associated with another condi-
tion [17,18]. Our limited prenatal ultrasound data sug-
gested that growth restriction began early in the second
trimester and worsened with increasing gestation. This
is consistent with others’ observations [10-13]. Taken
together our data confirm that intrauterine growth
restriction is a near universal finding with a gastroschisis
defect.
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Figure 5 Adjusted mean BW of gastroschisis cases (black line)
and controls (gray line) by gestational age with the 95%
confidence intervals represented by the error bars. The 10
th and
50
th centiles were obtained from published standards[24]. BW was
adjusted using the regression equation from Table 2 and included
maternal race, cigarette smoking, GHP, recreational drug use,
previous pregnancies and inborn status. From 33 weeks to about 38
weeks gestation, gastroschisis cases weighed progressively less than
controls, changing from -148 grams to -616 grams. The percentage
of BW deficit in gastroschisis cases increased from 7% at 33 weeks
gestation to 18% at 38 weeks. The small number of patients
available for analysis prior to 33 and after 38 weeks resulted in wide
confidence intervals and potentially unreliable estimates.
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actually greater than that seen with chromosomal
anomalies. The ponderal index was very slightly
increased, consistent with a reduction in length that was
proportional to the reduction in weight. The relatively
symmetrical nature of the growth restriction probably
reflects early onset [35]. Compounding intrauterine
growth deficits, GI dysfunction contributes to subopti-
mal nutrition after birth in the neonatal period [5,6,36].
Our findings imply that gastroschisis patients, because
of their marked intrauterine growth restriction, are at
increased risk for cardiovascular disease, adult-onset dia-
betes, and perhaps most importantly, intellectual disabil-
ity [37,38]. Leonard, et al., found that growth restriction
increased the odds of intellectual disability by about 71%
in a large Australian cohort [38]. Most gastroschisis
patients are born in the late preterm period (mean
gestational age at birth = 36 weeks). Late preterm birth
has also been associated with adverse cognitive and
socioemotional outcomes [39]. Gastroschisis patients
warrant close monitoring for developmental and intel-
lectual problems throughout childhood [40,41].
Our study extends pathogenetic considerations to
include the placenta. Placental histology suggested that
placental dysfunction may contribute to growth restric-
tion. Chorangiosis and severe villous edema were more
common in gastroschisis patients than in controls.
Chorangiosis is an increase in vascular channels in the
terminal villi of the placenta. It is thought to represent
fetal hypoxemia and the placenta’s attempt to improve
Table 3 Birth weight, length, and occipitofrontal circumference among NICU admissions with and without anomalies
Gastroschisis
(N = 179)
No major
anomaly
(N = 15,788)
Renal
anomalies
(N = 37)
Other GI
anomalies
(N = 130)
Chromosome
abnormalities
(N = 479)
Congenital heart
disease (N =
405)
Any other major
anomalies
(N = 4,040)
Gestational
age (wks)
35.7 ± 2.0 34.2 ± 4.0 34.1 ± 5.1 38.3 ± 2.7 36.5 ± 3.3 38.5 ± 2.2 33.7 ± 5.7
Unadjusted
BW (g)
2400 ± 502 2387 ± 918 2500 ± 1.140 3296 ± 701 2660 ± 861 3216 ± 638 2331 ± 118
BW z-score -0.64 ± 0.86 0.01 ± 0.93 0.25 ± 1.00 0.13 ± 0.96 -0.44 ± 1.3 -0.11 ± 0.98 -0.04 ± 1.14
BW
coefficient
a
-310 (-366, -254)
b Referent 45 (-93, 184) 26 (-55, 107) -244 (-298, -192)
b -94 (-141, -47)
b -7 (-23, 10)
Unadjusted
LT (cm)
45.7 ± 3.3 46.0 ± 5.7 44.8 ± 6.8 50.6 ± 3.6 46.7 ± 5.3 50.4 ± 3.7 44.3 ± 8.1
LT z-score -0.50 ± 1.19 0.42 ± 1.15 0.05 ± 1.69 0.57 ± 1.04 -0.37 ± 1.53 0.37 ± 1.24 0.11 ± 1.41
LT
coefficient
a
-2.1 (-2.5, -1.7)
b Referent -1.3 (-2.6, -0.1)
d -0.7 (-1.1, -0.2)
c -2.3 (-2.7, -2.0)
b -1.2 (-1.5, -0.9)
b -1.1 (-1.2, -1.0)
c
Unadjusted
OFC (cm)
31.9 ± 1.9 31.5 ± 3.5 31.0 ± 4.4 34.2 ± 2.3 31.9 ± 3.1 33.9 ± 1.9 30.7 ± 5.3
OFC z-score -0.36 ± 0.86 0.16 ± 1.02 0.04 ± 1.01 0.04 ± 0.97 -0.56 ± 1.30 -0.24 ± 0.95 0.15 ± 1.52
OFC
coefficient
a
-0.5 (-0.8, -0.3)
b referent -0.6 (-1.1, 0.1)
d -0.6 (-0.8, -0.3)
b -1.3 (-1.5, -1.2)
b -1.0 (-1.2, -0.9)
b -0.3 (-0.4, -0.2)
b
Ponderal
index
2.5 ± 0.37 2.3 ± 0.48 2.6 ± 0.89 2.5 ± 0.33 2.5 ± 0.49 2.5 ± 0.34 2.4 ± 0.53
PI z-score -0.06 ± 0.85 -0.24 ± 0.91 0.32 ± 1.86 -0.25 ± 0.53 -0.02 ± 1.18 -0.24 ± 0.59 -0.02 ± 1.17
PI
coefficient
a
0.10 (0.04, 0.15)
b referent 0.27 (0.00, 0.53)
d 0.01 (-0.04, 0.03) 0.10 (0.05, 0.15)
b -0.01 (-0.04, 0.03) 0.08 (0.06, 0.10)
b
a Determined using covariates gestational age, gender, multiple gestation status, maternal race, maternal cigarette smoking, GHP, pre-existing and gestational
diabetes, maternal illicit drug use, previous pregnancies, and inborn status. The regression model explained 82% of the variation in birth weight (R
2 = 0.818), 81%
of the variation in LT (R
2 = 0.810), 78% of the variation in OFC (R
2 = 0.777) and 10% of the variation of PI (R
2 = 0.103).
b p < 0.001
c p < 0.01
d p < 0.05
Table 4 Comparison of Estimated Fetal Weight by Ultrasound and Measured Birth Weight
Last ultrasound measurement (N = 61)
a Measurement at birth (N = 61)
a p-value
b
Weight (grams) median ( IQR
c) 1956 (1607-2273) 2300 (2050-2660) <0.001
Weight percentile median (IQR) 27 (8-38) 28 (10-42) 0.221
Gestational age (weeks) Median (IQR) 34 (33-36) 36 (34-37) <0.001
a There were 61 women who had an ultrasound exam at ≤ 3 weeks before delivery
b P-value determined by signed-rank test. The data were skewed and therefore non-parametric tests were used for this small data set.
c Interquartile range.
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weeks to develop. It has been associated with delivery at
high altitude, severe maternal anemia, and diabetes mel-
litus [31,32]. Villous edema also suggested placental dys-
function. In a separate study, we found evidence that
gestational hypertension is less common in the mothers
of gastroschisis patients [42]. The placenta plays a cen-
tral role in the development of gestational hypertension
[43]. It is unclear how the development of gastroschisis
in the fetus might be associated with decreased gesta-
tional hypertension in the mother. The placenta is often
small in cases of gestational hypertension associated
with fetal growth restriction [43]. However, we did not
find a significant difference in the placental weight z-
score between gastroschisis patients and controls. Stoll,
et al. also reported that placental size was not reduced
in a smaller series of gastroschisis cases [44]. These
findings, if confirmed, suggest that the placenta may
develop abnormally and lead to growth restriction in
gastroschisis cases, but not in the manner seen with
gestational hypertension.
The exact mechanism by which growth restriction
occurs in gastroschisis cases is not known. Carroll, et al.
reproted diminished cord serum protein and elevated
amniotic fluid protein in the amniotic fluid compared to
omphalocele patients and controls [45]. Unfortunately,
the patients and controls were not well matched with
respect to gestational age, which could have affected the
results. Protein loss through exudation of proteinaceous
fluid from the intestine, which is often inflamed and
exposed to the amniotic fluid throughout gestation,
might well contribute to poor intrauterine growth, but
probably would not account forc h o r a n g i o s i s .C h o r a n -
giosis provided indirect evidence of poor oxygen transfer
from the placenta to the fetus. The presence of intest-
inal obstruction or dysfunction did not likely contribute
to fetal growth restriction, since other GI anomalies,
most of which were atresias, were not associated with
decreased birth weight. It is possible that multiple
Table 5 Placental findings associated with gastroschisis
Placental findings Controls N = 29 Gastroschisis N = 31 p-value
Placental weight z-score (mean ± sd)
a 0.24 ± 1.29 -0.03 ± 1.07 0.804
b
Chorioamnionitis (%) 14 (48) 13 (42) 0.796
c
Any chorangiosis (%)
d 12 (41) 25 (81) 0.003
c
Focal chorangiosis (%)
d 8 (28) 12 (39) 0.419
c
Diffuse chorangiosis (%)
e 4 (14) 13 (42) 0.022
c
a Excludes the placentas of patients who were SGA (n = 9), had hydrops (n = 5), or both (n = 3).
b Rank-sum test
c Fisher exact test
d Focal chorangiosis was defined as ≥ 10 capillaries in ≥ 10 terminal villi in 10 fields at 10× magnification in each of 1-2 areas (slides).
e Diffuse chorangiosis was defined as ≥ 10 capillaries in ≥ 10 terminal villi in 10 fields at 10× magnification in each of 3 areas (slides).
Figure 6 Figure 6. A 10× photomicrograph of chorangiosis in a
placenta from a woman who delivered a patient with
gastroschisis. The arrow points to an area with multiple vascular
channels. Diffuse chorangiosis was defined as ≥ 10 capillaries in ≥
10 terminal villi in 10 fields at 10× magnification in each of 3 areas
(slides). Red blood cells can be seen in many of the capillaries.
Capillary proliferation can be seen in numerous terminal villi.
Figure 7 Figure 7. A 10× photomicrograph of a placenta from
a woman who delivered a control patient. Chorangiosis is not
present in this photmicrograph.
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sence of gastroschisis.
Several limitations should be considered when inter-
preting our study. All cases were referred and do not
represent population-based data. However, the demo-
graphic findings of our patients are similar to previous
reports [2-6]. Another concern might be error in physi-
cal measurements obtained by clinical personnel. BW of
gastroschisis patients could have been biased upward
due to bowel edema or the bandages used to protect
exposed intestine. However, nurses routinely weigh and
subtract the weight of bandages when recording BW.
Even if present, this bias would have reduced the
observed BW difference between cases and controls and
cannot explain our findings. Furthermore, measure-
ments of LT and OFC, were also low and not as likely
to have been influenced by the presence of gastroschisis.
We were limited in the number of prenatal ultrasounds
available for study. Patients were often evaluated and
received their prenatal ultrasounds at satellite clinics.
Only when patients received their prenatal ultrasound at
the main perinatal center were the ultrasound data
available to us. The strengths of this study are the large
numbers of patients examined, the multiple approaches
to quantifying the growth deficit and our examination of
placental findings.
Conclusion
We report that relatively symmetric, intrauterine growth
restriction occurs in almost all gastroschisis patients to
some degree. These growth deficits are comparable to
those seen in chromosomal disorders and are associated
with decreased length and head circumference. Growth
deficits increased from early in the second trimester
until delivery, and in many cases continued through
neonatal period. We found chorangiosis, a response to
tissue hypoxia, to be more common in gastroschisis
patients than in controls, which may implicate a placen-
tal contribution to growth restriction.
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